Yuexiandajisu E
Standard reference
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
Evid Based Complement Alternat Med.2018, 2018:4580627
Cell Physiol Biochem.2017, 43(4):1425-1435
J Health Sci Med Res.2023, 31584.
Phytomedicine.2018, 47:48-57
Food Chem X.2024, 24:101909.
Sci. Rep.2015, 14-23
BMC Plant Biol.2020, 20(1):214.
J Clin Transl Hepatol.2023, 11(4):863-876.
Psychopharmacology (Berl).2020, 10.1007
Toxicol In Vitro.2023, 93:105667.
Related and Featured Products
Planta Med. 2005 Apr;71(4):349-54.
Cytotoxic diterpenoids from the roots of Euphorbia ebracteolata.[Pubmed:
15856412]
METHODS AND RESULTS:
Three new diterpenoids, yuexiandajisu D (1), Yuexiandajisu E (2) and F were isolated from the roots of Euphorbia ebracteolata, along with eight known diterpenoids, jolkinolide B (4), jolkinolide A, ent-11alpha-hydroxyabieta-8(14),13(15)-dien-16,12alpha-olide (6), ent-(13S)-hydroxyatis-16-ene-3,14-dione, ent-3beta,(13S)-dihydroxyatis-16-en-14-one, ent-3-oxokaurane-16alpha,17-diol, ent-16alpha,17-dihydroxyatisan-3-one and ent-atisane-3beta,16alpha,17-triol.
CONCLUSIONS:
The structures of all compounds were deduced using spectroscopic methods and confirmed for 1 and Yuexiandajisu E by single-crystal X-ray diffraction. A biogenetic pathway for the formation of 1 and Yuexiandajisu E is proposed briefly.
